Sense4Baby is used to perform remote maternal and fetal monitoring including for high-risk pregnancies. The monitoring system received a CE mark from the European Commission in 2013 for commercialization in remote settings including self-administration.

AirStrip and Telenatal will make Sense4Baby available in the Netherlands, Austria, Belgium, Denmark, France, Germany, Italy, Luxembourg, Norway, Spain, Sweden, Switzerland and Turkey. Established in 2007, Telenatal aims to provide additional care choices to women facing increased medical risk during pregnancy.

"Our goal is to help pregnant patients stay as comfortable as possible while ensuring they receive the highest-quality care at all times," said Telenatal CEO Marco van Elst.

"AirStrip has a long-standing commitment to maternal-fetal health and safety. Sense4Baby allows us to extend interoperability and mobility to out of hospital settings to promote better outcomes, safety, and convenience," said AirStrip President Matt Patterson, MD.

AirStrip acquired the assets of Sense4Baby in 2014. It received 510(k) clearance from the US Food and Drug Administration (FDA) for remote use by medical professionals and is pending FDA clearance for self-administration.